7AEJ image
Deposition Date 2020-09-17
Release Date 2021-05-26
Last Version Date 2024-10-23
Entry Detail
PDB ID:
7AEJ
Keywords:
Title:
Crystal structure of asymmetric HIV-1 gp41 containing all membrane anchors
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.80 Å
R-Value Free:
0.30
R-Value Work:
0.26
R-Value Observed:
0.26
Space Group:
C 2 2 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp160,Envelope glycoprotein gp160
Chain IDs:A (auth: C), B (auth: A), C (auth: B)
Chain Length:192
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:2H10
Chain IDs:D
Chain Length:122
Number of Molecules:1
Biological Source:Lama glama
Ligand Molecules
Primary Citation
Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodies.
Elife 10 ? ? (2021)
PMID: 33871352 DOI: 10.7554/eLife.65005

Abstact

The HIV-1 gp120/gp41 trimer undergoes a series of conformational changes in order to catalyze gp41-induced fusion of viral and cellular membranes. Here, we present the crystal structure of gp41 locked in a fusion intermediate state by an MPER-specific neutralizing antibody. The structure illustrates the conformational plasticity of the six membrane anchors arranged asymmetrically with the fusion peptides and the transmembrane regions pointing into different directions. Hinge regions located adjacent to the fusion peptide and the transmembrane region facilitate the conformational flexibility that allows high-affinity binding of broadly neutralizing anti-MPER antibodies. Molecular dynamics simulation of the MPER Ab-stabilized gp41 conformation reveals a possible transition pathway into the final post-fusion conformation with the central fusion peptides forming a hydrophobic core with flanking transmembrane regions. This suggests that MPER-specific broadly neutralizing antibodies can block final steps of refolding of the fusion peptide and the transmembrane region, which is required for completing membrane fusion.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback